Skip to content

AbCellera Biologics Inc. ABCL Canada — Funding commitment received

Similar metrics at other companies

Murphy Oil logo
MURCanada — Commitments for capital expenditures
$49.8M+59.6%
Ares Management Corporation logo
ARESUnfunded capital commitments
$1.52B-2.3%
ConocoPhillips logo
COPCanada Operating Segment — Capital expenditures and investments
$121M-26.7%
LTC Properties logo
LTCReal Estate Investments Portfolio — Investment Commitments Total Amount Funded
$2.24M
KKR & Co. logo
KKRUnfunded commitments
$9.1B-15.7%
Royalty Pharma logo
RPRXTotal Funding, TEV-408 — Total Commitments
$75M

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.84B+59.2%
Enterprise value$1.88B+100.0%
P/S23.3×-26.8×

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept abcl:GovernmentAssistanceAwardAmountOtherExpenses.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s canada — funding commitment received.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s canada — funding commitment received?
AbCellera Biologics Inc. (ABCL) reported canada — funding commitment received of $94.4M in Q1 2026.
What does canada — funding commitment received mean?
Reflects the total value of financial commitments or grants formally pledged to the Canadian segment by government or external entities. This metric is a key indicator of the company's ability to secure external non-dilutive capital to support its research and development initiatives.